Clinical Trial Update: Lu AF28996 in Participants With Parkinson's Disease (PD) [Phase 1]

View source ↗

Summary

Phase 1 clinical trial of Lu AF28996 in Parkinson's disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Lu AF28996

Snippet

Sponsor: H. Lundbeck A/S | Conditions: Parkinson Disease | Phase 1 | Status: COMPLETED